东亚药业: 东亚药业第四届董事会第十次会议决议公告

Group 1 - The board of directors of Zhejiang Dongya Pharmaceutical Co., Ltd. held its tenth meeting of the fourth session, which was conducted both in-person and via communication methods [1][2] - All seven directors attended the meeting, and the meeting complied with relevant laws and regulations [1] - The board approved the proposal regarding the 2025 semi-annual report and its summary, which had been reviewed by the audit committee [1][2] Group 2 - The board also approved the special report on the storage and actual use of funds raised from the 2025 semi-annual convertible bonds, which was disclosed on the Shanghai Stock Exchange website [2] - The voting results for both proposals were unanimous, with 7 votes in favor and no votes against or abstentions [2]